Dr. Y.K. Hamied submits SEBI Takeover Code disclosure under Regulations 31(4) and 31(5)
Under SEBI's Substantial Acquisition of Shares and Takeovers Regulations 2011, Regulation 31(4) and 31(5) mandate disclosure when a person acquires or ceases to hold shares or voting rights that cross key thresholds (typically 5%, 10%, 15%, 20%, 25%, 30%, etc.) or when control changes hands. The filing with NSE indicates a material event affecting Cipla's shareholding structure. No acquisition value or shareholding percentage is disclosed in the regulatory filing itself; the substance of the disclosure would be in the appended form.
Why it mattersSubstantial change in promoter shareholding or voting control has crystallised; review whether this signals a succession event, family restructuring, or pledge/encumbrance triggering disclosure thresholds under the Takeover Code.
SectorPharma & Healthcare
[object Object][object Object][object Object][object Object][object Object][object Object][object Object]
Sources
- National Stock Exchange of India Limited - Corporate Announcements Archive · official
- SEBI - Takeover Regulations 2011 (Published Text) · official
- BSE corporate announcements · official
- NSE corporate announcements · official
- CCI combination orders · official
Related deals
- Yatharth Hospital & Trauma Care Services Limited: News Verification28 Aug 2026
- Yatharth Hospital & Trauma Care Services Limited: News Verification28 Aug 2026
- Trilegal acts on Berry Street - Healthify merger27 Aug 2026
- ChrysCapital-backed KIMS in talks to acquire minority stake in Renova Hospitals for $52M25-26 Aug 2026 · $52 million
- Mankind Pharma Limited: Other Restructuring26 Aug 2026
- Mankind Pharma Limited: Outcome of Board Meeting26 Aug 2026